Liver biopsy: when, how, by whom, and where?

被引:0
|
作者
McGill D.B. [1 ]
机构
[1] 200 First Steet, Mayo Clinic, SW, Rochester, 55905, MN
关键词
Liver Biopsy; International Normalize Ratio; Cavernous Hemangioma; Percutaneous Needle Biopsy; Percutaneous Liver Biopsy;
D O I
10.1007/s11894-001-0036-1
中图分类号
学科分类号
摘要
Liver biopsy remains an important diagnostic tool in the management of liver disease. Complications, though infrequent, are potentially disastrous. Risks and discomfort can be minimized with good technique, although prospective data to prove the superiority of one method over another are often lacking. Image direction is preferred in all cases, as is a transjugular approach when bleeding risks are judged to be high. Bleeding is essentially a random event. Outpatient liver biopsy is appropriate in almost every instance if immediate hospitalization facilities are available. It should be more widely practiced. Liver biopsies should only be done if, after thoughtful assessment, benefits are thought to exceed risks.
引用
收藏
页码:19 / 23
页数:4
相关论文
共 50 条
  • [31] NEW GENERATING CAPACITY - WHEN, WHERE AND BY WHOM
    BERMAN, IM
    [J]. POWER ENGINEERING, 1981, 85 (04) : 72 - 81
  • [32] NEW GENERATING PLANTS - WHEN, WHERE, AND BY WHOM
    PAPAMARCOS, J
    [J]. POWER ENGINEERING, 1985, 89 (04) : 24 - 31
  • [33] NEW GENERATING PLANTS - WHEN, WHERE, AND BY WHOM
    SMOCK, R
    [J]. POWER ENGINEERING, 1986, 90 (04) : 28 - 35
  • [34] When deficient lysosomes make the liver fatty and the arteries greasy: How to treat, whom and when?
    Lacaille, Florence
    [J]. JOURNAL OF HEPATOLOGY, 2022, 76 (03) : 501 - 502
  • [35] Mobile Exergaming in Adolescents' Everyday LifeContextual Design of Where, When, with Whom, and How: The SmartLife Case
    Schwarz, Ayla
    DeSmet, Ann
    Cardon, Greet
    Chastin, Sebastien
    Costa, Ruben
    Grilo, Antonio
    Ferri, Josue
    Domenech, Jorge
    Stragier, Jeroen
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2018, 15 (05)
  • [36] SENTINEL NODE WHEN, FOR WHOM AND HOW
    Kuehn, T.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 : 17 - 17
  • [37] PRENATAL KARYOTYPING - WHEN, HOW AND WHOM
    HOLZGREVE, W
    TERCANLI, S
    SCHNEIDER, HPG
    MINY, P
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1992, 2 (01) : 64 - 69
  • [38] How to distinguish a benign from a malignant tumour in children and when should a biopsy be done and by whom
    Salom, Marta
    Balaco, Ines
    [J]. EFORT OPEN REVIEWS, 2024, 9 (05) : 402 - 402
  • [39] When, for whom and how to use sibutramine?
    Astrup, A
    Toubro, S
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2001, 25 (Suppl 4) : S2 - S7
  • [40] Prophylactic Surgery: For Whom, When and How?
    Mau, Christine
    Untch, Michael
    [J]. BREAST CARE, 2017, 12 (06) : 379 - 384